Levels and patterns of prenatal alcohol exposure associated with increased risk of a clinically meaningful adverse effect on cognitive function
Alcohol, Clinical and Experimental Research · 2026
DOI: 10.1111/acer.70208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol, Clinical and Experimental Research, 2026. Verfasst von Joseph L Jacobson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Prenatal Exposure Delayed Effects, Alcohol Drinking, Cognition, Fetal Alcohol Spectrum Disorders. Die Arbeit nennt 60 Literaturangaben. Gefördert von: NIAAA NIH HHS, Lycaki-Young Fund from the State of Michigan, Australian Research Council Centre of Excellence for Mathematical and Statistical Frontiers.
Abstract (Originalsprache)
Background
Recent interest in the screening and diagnosis of fetal alcohol spectrum disorders (FASD) by the American Psychiatric Association and the American Association of Pediatrics has highlighted the lack of empirical evidence regarding the levels and patterns of prenatal alcohol exposure (PAE) associated with clinically significant adverse effects on cognitive and behavioral function. We used benchmark dose analysis to address this issue.
Methods
Benchmark dose analyses were performed on composite cognitive function scores derived from data obtained at school age, adolescence, and early adulthood from 2227 participants from six prospective, longitudinal cohorts, whose mothers were interviewed about their alcohol and drug use during pregnancy or shortly thereafter. We compared single‐predictor models based on average alcohol consumed per day during pregnancy with a two‐predictor, semiparametric model based on (1) average alcohol dose per drinking occasion and (2) drinking frequency.
Results
Our two‐predictor model showed that at lower levels of drinking frequency, a relatively high dose/occasion is required for an increased risk of poor intellectual function, whereas at higher levels of drinking frequency, a lower dose/occasion is sufficient to increase that risk. In addition, lower doses/occasion were associated with clinically meaningful adverse effects in participants born to older than to younger mothers. The single‐predictor models proved less adequate because the dose/occasion for a substantial proportion of participants exposed at the benchmark doses generated by those models was too low to increase the risk of clinically significant effects.
Conclusions
Given that the cognitive and behavioral deficits seen in FASD resemble those also seen in a range of other disorders, whether the patient's PAE is sufficient to increase the risk of clinically meaningful impairment is a critical element in an FASD diagnosis. Accurate diagnosis is needed to determine which patients warrant interventions that have been shown to be effective in remediating PAE‐related neurobehavioral impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA.
- Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada.
- Department of Biostatistics, School of Medicine, Ankara University, Ankara, Turkey.
- Department of Emergency Medicine, Institute of Human Nutrition, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
- Department of Pediatrics, Institute of Human Nutrition, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
ORCID-Profile: Joseph L Jacobson, Sandra W Jacobson, R Colin Carter, Claire D Coles, Heather Carmichael Olson, Neil C Dodge
Förderung
- NIAAA NIH HHS
- Lycaki-Young Fund from the State of Michigan
- Australian Research Council Centre of Excellence for Mathematical and Statistical Frontiers
- Natural Sciences and Engineering Research Council of Canada
- NIDA NIH HHS
- Eunice Kennedy Shriver National Institute on Child Health and Human Development
- NIDA/NIH
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Jacobson, J. L., Akkaya-Hocagil, T., Jacobson, S. W., Carter, R. C., Coles, C. D., Richardson, G. A., Olson, H. C., Day, N. L., Dodge, N. C., Cook, R. J., & Ryan, L. M. (2026). Levels and patterns of prenatal alcohol exposure associated with increased risk of a clinically meaningful adverse effect on cognitive function. Alcohol, Clinical and Experimental Research. https://doi.org/10.1111/acer.70208
Vancouver
Jacobson JL, Akkaya-Hocagil T, Jacobson SW, Carter RC, Coles CD, Richardson GA, et al. Levels and patterns of prenatal alcohol exposure associated with increased risk of a clinically meaningful adverse effect on cognitive function. Alcohol, Clinical and Experimental Research. 2026. doi:10.1111/acer.70208
BibTeX
@article{Jacobson2026,
author = {Jacobson, Joseph L and Akkaya-Hocagil, Tugba and Jacobson, Sandra W and Carter, R Colin and Coles, Claire D and Richardson, Gale A and Olson, Heather Carmichael and Day, Nancy L and Dodge, Neil C and Cook, Richard J and Ryan, Louise M},
title = {Levels and patterns of prenatal alcohol exposure associated with increased risk of a clinically meaningful adverse effect on cognitive function},
journal = {Alcohol, Clinical and Experimental Research},
year = {2026},
doi = {10.1111/acer.70208}
}
EUVIMED